One day, we may be able to detect signs that age-related macular degeneration (AMD) is developing and take early steps to defend against it. Macular Degeneration Research is funding research into unique ways to protect the retinal pigment epithelium (RPE) and retina at earlier stages, before damage to sight has occurred. These include drugs that enhance immune functioning and improve the eye’s ability to clear lipids/fats and other waste that might otherwise lead to inflammation in AMD.

New imaging techniques are being developed that will help us to do a better job of tracking disease progression over time. Knowledge of genetics is advancing to the point that gene therapy is being evaluated as a possibility to treat AMD.

 

 

Explore More of Our 360° Approach